MedTech News
Lung-on-a-chip with working immune system protects itself like a living organ
Georgia Tech and Vanderbilt researchers have built the first lung-on-a-chip with a working immune system, a breakthrough with the potential to reshape how we study disease, move beyond animal testing, and administer lifesaving therapies.
A more precise CRISPR platform enables large-scale gene screening in live mouse brains
Over the past few decades, biomedical researchers and neuroscientists have devised increasingly advanced techniques to study and alter neurophysiological processes.
Smart Meter launches new sensor for contactless patient monitoring
iAmbientHealth tracks vital signs such as heart rate, respiration, movement, and bed exit, leveraging radar technology.
Northwestern University announces new RNA detection method for cancer
The study introduced LIME-seq, a new non-invasive technique capable of detecting RNA modifications at a detailed level across different RNA types.
First patient treated with Medtronic Altaviva following FDA nod
Medtronic (NYSE: MDT)+
today reported the first patient treated with its Altaviva neuromodulation device for urge urinary incontinence.
Bunkerhill Secures FDA Clearance for ECG-EF, Using AI to Detect Reduced Ejection Fraction from Routine ECGs
SAN FRANCISCO, Sept. 23, 2025 /PRNewswire/ — Bunkerhill Health today announced it has received U.S. Food and Drug Administration (FDA) clearance for ECG-EF, an artificial intelligence algorithm that detects reduced left ventricular ejection fraction (LVEF), a key indicator of heart failure, using data from routine 12-lead electrocardiograms (ECGs).
Arthrex Achieves First Case with NanoNeedle™ Scope 2.0
NAPLES, Fla., Sept. 23, 2025 /PRNewswire/ — Arthrex, a global leader in minimally invasive surgical technology, announced the launch of NanoNeedle™ scope 2.0, the latest version of the company’s minimally invasive imaging platform. The technology was recently used for the first time in a clinical case by Kyle Anderson, MD, at Anderson Sports Medicine in Bingham Farms, Michigan.
Noul Secures FDA Registration for Cervical Cancer Diagnostic Cartridge
YONGIN, South Korea, Sept. 23, 2025 /PRNewswire/ — Noul Co., Ltd. (CEO: David Lim), a medical AI company specializing in blood and cancer diagnostics, announced that FDA registration has been completed for its cervical cancer diagnostic cartridge miLab™ Cartridge CER and clearing agent SafeFix™ CER, both core components of the company’s cervical cancer diagnostic solution miLab™ CER.